111 related articles for article (PubMed ID: 12953138)
1. Allogeneic CD34-enriched peripheral blood stem cell transplantation in a patient with paroxysmal nocturnal haemoglobinuria.
Ditschkowski M; Trenschel R; Kummer G; Elmaagacli AH; Beelen DW
Bone Marrow Transplant; 2003 Sep; 32(6):633-5. PubMed ID: 12953138
[TBL] [Abstract][Full Text] [Related]
2. Assessing donor chimerism using flow cytometry in paroxysmal nocturnal haemoglobinuria after stem cell transplantation--a case report.
Azma RZ; Hamidah NH; Leong CF; Ainoon O; Cheong SK
Malays J Pathol; 2006 Dec; 28(2):107-12. PubMed ID: 18376800
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases.
Lang P; Klingebiel T; Bader P; Greil J; Schumm M; Schlegel PG; Eyrich M; Mueller-Weihrich S; Niethammer D; Handgretinger R
Bone Marrow Transplant; 2004 Jan; 33(1):25-32. PubMed ID: 14704654
[TBL] [Abstract][Full Text] [Related]
4. [Stem cell transplantation for paroxysmal nocturnal hemoglobinuria].
Cermák J; Vítek A; Marinov I; Písacka M; Brabec V
Vnitr Lek; 2000 Jun; 46(6):319-22. PubMed ID: 15645835
[TBL] [Abstract][Full Text] [Related]
5. Mixed chimerism is frequent after allogeneic peripheral blood stem cell transplantation with positive CD34 selection, and is not reverted by low doses of donor T-cells add-back.
Rodríguez-Luaces M; Ferrá C; Martín-Henao G; Berlanga JJ; Grañena A; Gallardo D
Eur J Haematol; 2004 Sep; 73(3):162-8. PubMed ID: 15287912
[TBL] [Abstract][Full Text] [Related]
6. Selected CD34 blood cell allografts for older patients: low transplant-related mortality, graft failure and acute GvHD.
Roberts MM; Dyson P; Rawling C; Thorp D; Rawling T; White D; Horvath N; Bardy P; Hui CH; Dart GW; To LB; Hughes TP
Cytotherapy; 2003; 5(6):534-41. PubMed ID: 14660049
[TBL] [Abstract][Full Text] [Related]
7. Outcome of allogeneic peripheral blood stem cell transplantation using matched sibling donors in patients with high-risk hematological diseases.
Sohn SK; Kim DH; Kim JG; Sung WJ; Baek JH; Lee NY; Won DI; Suh JS; Lee KS; Lee KB
Eur J Haematol; 2004 Jun; 72(6):430-6. PubMed ID: 15128422
[TBL] [Abstract][Full Text] [Related]
8. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation.
Kim DH; Won DI; Lee NY; Sohn SK; Suh JS; Lee KB
Biol Blood Marrow Transplant; 2006 Jul; 12(7):719-28. PubMed ID: 16785061
[TBL] [Abstract][Full Text] [Related]
9. CD34(+)-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation.
Oyekunle A; Koehl U; Schieder H; Ayuk F; Renges H; Fehse N; Zabelina T; Fehse B; Klingebiel T; Sputtek A; Zander A; Kröger N
Cytotherapy; 2006; 8(4):375-80. PubMed ID: 16923613
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria.
Bemba M; Guardiola P; Garderet L; Devergie A; Ribaud P; Esperou H; Noguera MH; Gluckman E; Socié G
Br J Haematol; 1999 May; 105(2):366-8. PubMed ID: 10233405
[TBL] [Abstract][Full Text] [Related]
11. Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors.
Kim DH; Sohn SK; Lee NY; Baek JH; Kim JG; Won DI; Suh JS; Lee KB; Shin IH
Eur J Haematol; 2005 Oct; 75(4):299-308. PubMed ID: 16146536
[TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
13. Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults.
Dykes JH; Toporski J; Juliusson G; Békássy AN; Lenhoff S; Lindmark A; Scheding S
Transfusion; 2007 Nov; 47(11):2134-42. PubMed ID: 17958543
[TBL] [Abstract][Full Text] [Related]
14. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
[TBL] [Abstract][Full Text] [Related]
15. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
Larocca A; Piaggio G; Podestà M; Pitto A; Bruno B; Di Grazia C; Gualandi F; Occhini D; Raiola AM; Dominietto A; Bregante S; Lamparelli T; Tedone E; Oneto R; Frassoni F; Van Lint MT; Pogliani E; Bacigalupo A
Haematologica; 2006 Jul; 91(7):935-40. PubMed ID: 16818281
[TBL] [Abstract][Full Text] [Related]
16. Haploidentical transplantation for acute lymphoblastic leukemia in childhood.
Klingebiel T; Handgretinger R; Lang P; Bader P; Niethammer D
Blood Rev; 2004 Sep; 18(3):181-92. PubMed ID: 15183902
[TBL] [Abstract][Full Text] [Related]
17. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
[TBL] [Abstract][Full Text] [Related]
18. Conditioning with high-dose cyclophosphamide may not be sufficient to provide a long-term remission of paroxysmal nocturnal hemoglobinuria following syngeneic peripheral blood stem cell transplantation.
Cho SG; Lim J; Kim Y; Eom HS; Jin CY; Han CW; Kim CC
Bone Marrow Transplant; 2001 Nov; 28(10):987-8. PubMed ID: 11753556
[TBL] [Abstract][Full Text] [Related]
19. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K
Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
[TBL] [Abstract][Full Text] [Related]
20. Kinetics and immunophenotypic characterization of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation.
Albo C; de la Fuente J; Ares C; Alonso C; Feteira E
Haematologica; 2004 Jul; 89(7):845-51. PubMed ID: 15257937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]